Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases

Archives of Surgery

Volumn 142, Issue 7, 2007, Pages 675-682

  Gulec, Seza A ^a   Fong, Yuman ^b  

^a Goshen Health System Center for Cancer Care   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MICROSPHERE; NARCOTIC ANALGESIC AGENT; OXALIPLATIN; UNCLASSIFIED DRUG; YTTRIUM 90; YTTRIUM 90 MICROSPHERE;

ABDOMINAL PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL STUDY; COLORECTAL CANCER; DRUG DOSE ESCALATION; DUODENUM ULCER; FEVER; HEPATIC COLORECTAL CANCER; HUMAN; LETHARGY; LIVER CANCER; LIVER TOXICITY; METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SALVAGE THERAPY; STOMACH ULCER; TREATMENT OUTCOME;

BRACHYTHERAPY; COLONIC NEOPLASMS; HUMANS; LIVER NEOPLASMS; MICROSPHERES; NEOADJUVANT THERAPY; RADIOPHARMACEUTICALS; RANDOMIZED CONTROLLED TRIALS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 34447502039     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.7.675     Document Type: Review

References (24)

1. Ariel IM, Pack GT. Treatment of inoperable cancer of the liver by intra-arterial radioactive isotopes and chemotherapy. Cancer. 1967;20(5):793-804.
2. Ariel IM, Padula G. Treatment of symptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1978;10(4):327-336.
3. Ariel IM, Padula G. Treatment of asymptomatic metastatic cancer to the liver from primary colon and rectal cancer by the intra-arterial administration of chemotherapy and radioactive isotopes. J Surg Oncol. 1982;20(3):151-156.
4. Gray BN, Burton MA, Kelleher D, et al. Tolerance of the liver to the effects of Yttrium-90 radiation. Int J Radiat Oncol Biol Phys. 1990;18(3):619-623.
5. Meade VM, Burton MA, Gray BN, Self GW. Distribution of different sized microspheres in experimental hepatic tumors. Eur J Cancer Clin Oncol. 1987;23(1):37-41.
6. Stribley KV, Gray BN, Chmiel RL, Heggie JCP, Bennett RC. Internal radiotherapy for hepatic metastases: the homogeneity of hepatic arterial blood flow J Surg Res. 1983;34(1):17-24.
7. Gray B, Van Hazel G, Hope M, et al. Randomized trial of SIR-Spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001;12(12):1711-1720.
8. Van Hazel G, Blackwell A, Anderson J, et al. Randomized phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol. 2004;88(2):78-85.
9. Sharma RA, Van Hazel GA, Morgan B, et al. Radioembolization of liver metastases from colorectal cancer using Yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol. 2007;25(9):1099-1106.
10. Van Hazel G, Pavlakis N, Goldstein D, Oliver I. Selective Internal Radiation Therapy (SIRT) plus systemic chemotherapy with irinotecan: a phase I dose escalation study. Paper presented at: ASCO GI Symposium; January 27, 2005; Hollywood, FL.
11. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy with yttrium-90 microspheres for extensive colorectal cancer metastases. J Gastrointest Surg. 2001;5(3):294-302.
12. Kennedy AS, Coldwell D, Nutting C, et al. Resin Y-90-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys. 2006;65(2):412-425.
13. Gulec SA, Mesoloras G, Pennington K, Bruetman D, Wheeler J, Hostetter R, Schwartzentruber D. Phase 2 efficacy and safety study of chemotherapy with selective internal radiation treatment using Y90 resin microspheres (chemo-SIRT) in patients with colorectal cancer liver metastasis. Paper presented at: Emerging Trends in Radioembolization Using Microspheres; May 4, 2007; Chicago, IL.
14. Gulec SA, Mesoloras G, Dezarn WA, McNeillie P, Kennedy AS. Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver ratio. J Transl Med. 2007;5:15.
15. Gulec SA, Mesoloras G, Stabin M. Dosimetric techniques in Y-90 microsphere therapy of liver cancer: the MIRD equations for dose calculations. J Nucl Med. 2006;47(7):1209-1211.
16. Dancey JE, Shepherd FA, Paul K, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41(10):1673-1681.
17. Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200-208.
18. Gray BN. Colorectal cancer: the natural history of disseminated disease. Aust N Z J Surg. 1980;50(6):643-646.
19. Fong Y. Surgical therapy of hepatic colorectal metastasis. CA Cancer J Clin. 1999;49(4):231-255.
20. Alberts SR, Horvath WL, Sternfeld WC, et al. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group Phase II Study. J Clin Oncol. 2005;23(36):9243-9249.
21. Bismuth H, Adam R. Reduction of non-resectable liver metastases from colorectal cancer after oxaliplatin chemotherapy. Semin Oncol. 1998;25(2)(suppl 5):40-46.
22. Delaunoit T, Alberts SR, Sargent DJ, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol. 2005;16(3):425-429.
23. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240(4):644-657.
24. McCarter MD, Fong Y. Role for surgical cytoreduction in multimodality treatments for cancer. Ann Surg Oncol. 2001;8(1):38-43.